Tech Mahindra Joins StaTwig in Global Vaccine-Tracing Blockchain

The firms say the blockchain can improve transparency and prevent failures in global vaccine supply chains.

Jul 5, 2021 at 11:18 a.m. UTC

Updated Sep 14, 2021 at 1:20 p.m. UTC

Indian IT giant Tech Mahindra is working with blockchain startup StaTwig on a blockchain-based product for tracing global vaccine supply chains.

The IT firm said Monday the VaccineLedger blockchain is designed to improve transparency and prevent failures in vaccine supply, including the distribution of expired vaccines, stock depletion and counterfeiting.
Tech Mahindra, a subsidiary of Indian conglomerate Mahindra Group, has joined with StaTwig, a startup based in Hyderabad and Singapore. The company created the system to trace vaccines from manufacturers to consumers.
In the statement, the companies did not say when the product was likely to become available.
The two will work to create a global network of vaccine researchers, governments, pharmaceutical companies, distributors and health-care workers, according to the announcement.
This is not the first time Tech Mahindra has shown interest in blockchain solutions. Last year, it began working with local edutech firm Idealabs to develop blockchain talent in India, and later announced it will offer blockchain solutions to global customers using Amazon Web Services (AWS).

DISCLOSURE

Please note that our privacy policy, terms of use, cookies, and do not sell my personal information has been updated.

The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.